Witnessing the stock’s movement on the chart, on November 23, 2022, Tenaya Therapeutics Inc. (NASDAQ: TNYA) had a quiet start as it plunged -4.31% to $2.44. During the day, the stock rose to $2.59 and sunk to $2.265 before settling in for the price of $2.55 at the close. Taking a more long-term approach, TNYA posted a 52-week range of $1.73-$22.87.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -320.00%. This publicly-traded company’s shares outstanding now amounts to $41.36 million, simultaneously with a float of $37.87 million. The organization now has a market capitalization sitting at $106.46 million. At the time of writing, stock’s 50-day Moving Average stood at $2.77, while the 200-day Moving Average is $6.69.
Tenaya Therapeutics Inc. (TNYA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Tenaya Therapeutics Inc.’s current insider ownership accounts for 8.48%, in contrast to 84.00% institutional ownership. According to the most recent insider trade that took place on Nov 21, this organization’s 10% Owner bought 9,615,384 shares at the rate of 2.60, making the entire transaction reach 24,999,998 in total value, affecting insider ownership by 9,615,384. Preceding that transaction, on Nov 21, Company’s Director bought 9,615,384 for 2.60, making the whole transaction’s value amount to 24,999,998. This particular insider is now the holder of 9,615,384 in total.
Tenaya Therapeutics Inc. (TNYA) Earnings and Revenue Records
As on 6/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$0.69 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.76) by $0.07. This company achieved a return on equity of -73.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
Tenaya Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -320.00% and is forecasted to reach -2.69 in the upcoming year.
Tenaya Therapeutics Inc. (NASDAQ: TNYA) Trading Performance Indicators
Let’s observe the current performance indicators for Tenaya Therapeutics Inc. (TNYA). It’s Quick Ratio in the last reported quarter now stands at 8.90. The Stock has managed to achieve an average true range (ATR) of 0.38.
In the same vein, TNYA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.81, a figure that is expected to reach -0.66 in the next quarter, and analysts are predicting that it will be -2.69 at the market close of one year from today.
Technical Analysis of Tenaya Therapeutics Inc. (TNYA)
Going through the that latest performance of [Tenaya Therapeutics Inc., TNYA]. Its last 5-days volume of 1.14 million indicated improvement to the volume of 0.18 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 37.64% While, its Average True Range was 0.40.